Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/taylor-francis/androgen-receptor-serine-81-mediates-pin1-interaction-and-activity-LApNmkqQpG
References (52)
-
Review Nuclear Receptor Signaling | The Open Access Journal of the Nuclear Receptor Signaling Atlas AR, the cell cycle, and prostate cancer -
L. Bao, A. Kimzey, G. Sauter, J. Sowadski, K. Lu, Dagong Wang (2004)
Prevalent overexpression of prolyl isomerase Pin1 in human cancers.The American journal of pathology, 164 5
-
Gioeli (2002)
Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sitesJ Biol Chem, 277
-
P. Blume-Jensen, T. Hunter (2001)
Oncogenic kinase signallingNature, 411
-
Balk (2008)
AR, the cell cycle, and prostate cancerNucl Recept Signal, 6
-
D. Gioeli, B. Black, Vicki Gordon, Adam Spencer, C. Kesler, S. Eblen, B. Paschal, M. Weber (2006)
Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization.Molecular endocrinology, 20 3
-
A. Sivanandam, Shalini Murthy, K. Chinnakannu, V. Bai, Sahn-Ho Kim, E. Barrack, M. Menon, G. Reddy (2011)
Calmodulin protects androgen receptor from calpain‐mediated breakdown in prostate cancer cellsJournal of Cellular Physiology, 226
-
P. Lonergan, D. Tindall (2011)
Androgen receptor signaling in prostate cancer development and progressionJournal of Carcinogenesis, 10
-
V. Brondani, Q. Schefer, F. Hamy, T. Klimkait (2005)
The peptidyl–prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor α stabilityBiochemical and Biophysical Research Communications, 328
-
Zhou (1995)
Identification of three proline-directed phosphorylation sites in the human androgen receptorMol Endocrinol, 9
-
Zhong-xun Zhou, J. Kemppainen, E. Wilson (1995)
Identification of three proline-directed phosphorylation sites in the human androgen receptor.Molecular endocrinology, 9 5
-
G. Ayala, Dagong Wang, G. Wulf, A. Frolov, Rile Li, J. Sowadski, T. Wheeler, K. Lu, L. Bao (2003)
The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.Cancer research, 63 19
-
N. Dubrawsky (1989)
Cancer statisticsCA: A Cancer Journal for Clinicians, 39
-
F. Rizzolio, I. Caligiuri, C. Lucchetti, R. Fratamico, V. Tomei, Gaia Gallo, A. Agelan, G. Ferrari, G. Toffoli, Andres Klein-Szanto, A. Giordano (2013)
Dissecting Pin1 and phospho‐pRb regulationJournal of Cellular Physiology, 228
-
(2010)
The promise of novel androgen receptor antagonists -
J. Elo, T. Visakorpi (2003)
Molecular genetics of prostate cancer.Annals of medicine, 33 2
-
M. Fu, Mahadev Rao, Kongming Wu, Chenguang Wang, Xueping Zhang, M. Hessien, Y. Yeung, D. Gioeli, M. Weber, R. Pestell (2004)
The Androgen Receptor Acetylation Site Regulates cAMP and AKT but Not ERK-induced Activity*Journal of Biological Chemistry, 279
-
P. Riegman, R. Vlietstra, J. Korput, A. Brinkmann, J. Trapman (1991)
The promoter of the prostate-specific antigen gene contains a functional androgen responsive element.Molecular endocrinology, 5 12
-
J. Laar, C. Berrevoets, J. Trapman, Netty Zegers, A. Brinkmann (1991)
Hormone-dependent androgen receptor phosphorylation is accompanied by receptor transformation in human lymph node carcinoma of the prostate cells.The Journal of biological chemistry, 266 6
-
M. Napoli, J. Girardini, Silvano Piazza, G. Sal (2011)
Wiring the oncogenic circuitry: Pin1 unleashes mutant p53Oncotarget, 2
-
A. Jemal, Taylor Murray, Elizabeth Ward, A. Samuels, R. Tiwari, Asma Ghafoor, E. Feuer, M. Thun (2005)
Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 55
-
C. Ryan, D. Tindall (2011)
Androgen receptor rediscovered: the new biology and targeting the androgen receptor therapeutically.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 27
-
V. Brondani, Q. Schefer, F. Hamy, T. Klimkait (2005)
The peptidyl-prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor alpha stability.Biochemical and biophysical research communications, 328 1
-
H. Poukka, U. Karvonen, Olli Jänne, J. Palvimo (2000)
Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).Proceedings of the National Academy of Sciences of the United States of America, 97 26
-
Shaoyong Chen, Youyuan Xu, Xin Yuan, G. Bubley, S. Balk (2006)
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1Proceedings of the National Academy of Sciences, 103
-
Y. Fujimoto, T. Shiraki, Yuji Horiuchi, Tsuyoshi Waku, Akira Shigenaga, A. Otaka, T. Ikura, K. Igarashi, S. Aimoto, S. Tate, K. Morikawa (2009)
Proline cis/trans-Isomerase Pin1 Regulates Peroxisome Proliferator-activated Receptor γ Activity through the Direct Binding to the Activation Function-1 Domain*The Journal of Biological Chemistry, 285
-
M. Centenera, Jonathan Harris, W. Tilley, L. Butler (2008)
The contribution of different androgen receptor domains to receptor dimerization and signaling.Molecular endocrinology, 22 11
-
D. Gioeli, B. Paschal (2012)
Post-translational modification of the androgen receptorMolecular and Cellular Endocrinology, 352
-
M. Fu, Chenguang Wang, Jian Wang, Xueping Zhang, T. Sakamaki, Y. Yeung, Chawnshang Chang, T. Hopp, S. Fuqua, E. Jaffray, Ronald Hay, J. Palvimo, O. Jänne, R. Pestell (2002)
Androgen Receptor Acetylation Governs trans Activation and MEKK1-Induced Apoptosis without Affecting In Vitro Sumoylation and trans-Repression FunctionMolecular and Cellular Biology, 22
-
B. Feldman, D. Feldman (2001)
The development of androgen-independent prostate cancerNature Reviews Cancer, 1
-
R. Ward, N. Weigel (2009)
Steroid receptor phosphorylation: Assigning function to site‐specific phosphorylationBioFactors, 35
-
J. Laar, J. Vries, Netty Zegers, J. Trapman, Albert Brinkmann (1990)
Androgen receptor heterogeneity and phosphorylation in human LNCaP cells.Biochemical and biophysical research communications, 166 1
-
M. Frezza, Huanjie Yang, Q. Dou (2011)
Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuliJournal of Cellular Physiology, 226
-
A. Ryo, H. Uemura, H. Ishiguro, T. Saitoh, A. Yamaguchi, K. Perrem, Y. Kubota, K. Lu, I. Aoki (2005)
Stable Suppression of Tumorigenicity by Pin1-Targeted RNA Interference in Prostate CancerClinical Cancer Research, 11
-
M. Beato (1989)
Gene regulation by steroid hormonesCell, 56
-
D. Loblaw, Katherine Virgo, R. Nam, M. Somerfield, E. Ben-Josef, D. Mendelson, R. Middleton, S. Sharp, Thomas Smith, J. Talcott, M. Taplin, N. Vogelzang, J. Wade, C. Bennett, H. Scher (2007)
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 12
-
F. Rizzolio, C. Lucchetti, I. Caligiuri, I. Marchesi, M. Caputo, Andres Klein-Szanto, L. Bagella, M. Castronovo, A. Giordano (2012)
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1Cell Death and Differentiation, 19
-
K. Mahajan, N. Mahajan (2010)
Shepherding AKT and androgen receptor by Ack1 tyrosine kinaseJournal of Cellular Physiology, 224
-
S. Baniwal, Gillian Little, N. Chimge, B. Frenkel (2012)
Runx2 controls a feed‐forward loop between androgen and prolactin‐induced protein (PIP) in stimulating T47D cell proliferationJournal of Cellular Physiology, 227
-
Natalia Narizhneva, N. Tararova, Petro Ryabokon, Inna Shyshynova, A. Prokvolit, P. Komarov, A. Purmal, A. Gudkov, K. Gurova (2009)
Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancerCell Cycle, 8
-
Shaoyong Chen, G. Wulf, Xiao Zhou, M. Rubin, K. Lu, S. Balk (2006)
Activation of β-Catenin Signaling in Prostate Cancer by Peptidyl-Prolyl Isomerase Pin1-Mediated Abrogation of the Androgen Receptor-β-Catenin InteractionMolecular and Cellular Biology, 26
-
(2005)
55:10-30; PMID:15661684; http://dx.doi. org/10.3322/canjclin.55.1.10 -
E. Gelmann (2002)
Molecular biology of the androgen receptor.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 13
-
Vicki Gordon, Shriti Bhadel, Winfried Wunderlich, Joann Zhang, S. Ficarro, S. Mollah, J. Shabanowitz, D. Hunt, I. Xenarios, W. Hahn, M. Conaway, M. Carey, D. Gioeli (2010)
CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.Molecular endocrinology, 24 12
-
C. Kesler, D. Gioeli, M. Conaway, M. Weber, B. Paschal (2007)
Subcellular localization modulates activation function 1 domain phosphorylation in the androgen receptor.Molecular endocrinology, 21 9
-
Regulation of Estrogen Receptor (cid:1) N-Terminus Conformation and Function by Peptidyl Prolyl Isomerase Pin1 -
B. Berman, B. Frenkel, G. Coetzee, L. Jia (2010)
Androgen receptor responsive enhancers are flanked by consistently-positioned H3-acetylated nucleosomesCell Cycle, 9
-
A. Słupianek, Smitha Yerrum, F. Safadi, M. Monroy (2010)
The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cellsJournal of Cellular Physiology, 224
-
N. Guseva, O. Rokhlin, T. Bair, Rebecca Glover, Michael Cohen (2012)
Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptorOncotarget, 3
-
Abate-Shen (2000)
Molecular genetics of prostate cancerGenes Dev, 14
-
M. Gianni’, Andrea Boldetti, Valeria Guarnaccia, A. Rambaldi, Edoardo Parrella, I. Raška, C. Rochette-Egly, G. Sal, A. Rustighi, M. Terao, E. Garattini (2009)
Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha.Cancer research, 69 3
-
Shaoyong Chen, G. Wulf, Xiao Zhou, M. Rubin, K. Lu, S. Balk (2006)
Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.Molecular and cellular biology, 26 3
- Publisher
- Taylor & Francis
- Copyright
- Copyright © 2012 Landes Bioscience
- ISSN
- 1551-4005
- eISSN
- 1538-4101
- DOI
- 10.4161/cc.21730
- pmid
- 22894932
- Publisher site
- See Article on Publisher Site
Abstract
Hormone-dependent tumors are characterized by deregulated activity of specific steroid receptors, allowing aberrant expression of many genes involved in cancer initiation, progression and metastasis. In prostate cancer, the androgen receptor (AR) protein has pivotal functions, and over the years it has been the target of different drugs. AR is a nuclear receptor whose activity is regulated by a phosphorylation mechanism controlled by hormone and growth factors. Following phosphorylation, AR interacts with many cofactors that closely control its function. Among such cofactors, Pin1 is a peptidyl-prolyl isomerase that is involved in the control of protein phosphorylation and has a prognostic value in prostate cancer. In the present study, we demonstrate that ARSer81 is involved in the interaction with Pin1, and that this interaction is important for the transcriptional activity of AR. Since Pin1 expression positively correlates with tumor grade, our results suggest that Pin1 can participate in this process by modulating AR function.
Journal
Cell Cycle – Taylor & Francis
Published: Sep 15, 2012
Keywords: phosphorylation; prostate cancer; androgen receptor; ARSer81; Pin1